Product Name

  • Name

    Taurine

  • EINECS 203-483-8
  • CAS No. 107-35-7
  • Article Data133
  • CAS DataBase
  • Density 1.494 g/cm3
  • Solubility water: 0.5 M at 20 °C, clear, colorless
  • Melting Point >300 °C(lit.)
  • Formula C2H7NO3S
  • Boiling Point
  • Molecular Weight 125.148
  • Flash Point
  • Transport Information
  • Appearance White crystalline powder
  • Safety 26-36-24/25
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 107-35-7 (Taurine)
  • Hazard Symbols IrritantXi
  • Synonyms 2-aminoethanesulfonic acid;aminoetylsulphonic acid;Aminoethylsulfonic acid (JAN);2-aminoethyl sulfonate;beta-aminoethylsulfonic acid;Taufon;Aminoethylsulfonic acid;O-Due;2-Sulfoethylamine;Ethanesulfonic acid, 2-amino- (9CI);Aminoethanesulfonic acid;Taurine (8CI);Taukard;L-Taurine;2-Aminoethylsulfonic acid;2-azaniumylethanesulfonate;ethanesulfonic acid, 2-amino-;ethylaminesulphonic acid;2-aminoethylsulfonic acid, ethlaminosulfonic acid;2-Aminoethanesulphonic acid >99%;2-amino ethanesulfonic acid;Taurine JP8 (food, feed & pharmaceutical grade);Taurine (P015);2-Aminoethansulfonic;;2-Amino ethyl sulfonic acid;
  • PSA 88.77000
  • LogP 0.61400

Synthetic route

cyanomethane-sulfonic acid
753386-85-5

cyanomethane-sulfonic acid

Conditions
ConditionsYield
With hydrogen at 55℃; under 22502.3 Torr; Temperature; Pressure; Reagent/catalyst; Inert atmosphere;99.98%
Cysteamine
60-23-1

Cysteamine

Conditions
ConditionsYield
With 2,2,6,6-tetramethyl-piperidine In water at 140℃; under 3000.3 Torr; for 0.166667h; Reagent/catalyst; Temperature; Pressure;98.4%
With dihydrogen peroxide; acetic acid
sodium taurinate
7347-25-3

sodium taurinate

Conditions
ConditionsYield
With ethanolamine pH=12.5;95.7%
With sulfuric acid at 80 - 100℃; pH=7.9; Temperature; pH-value;75%
With sulfur dioxide In water pH=5 - 6; Reagent/catalyst;110 g
ammonium 2-nitroethane-1-sulfonate
856367-27-6

ammonium 2-nitroethane-1-sulfonate

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen at 20℃; pH=4.2; Concentration; pH-value; Temperature; Reagent/catalyst; Large scale;95.1%
sodium 2-hydroxyethanesulfonate
1562-00-1

sodium 2-hydroxyethanesulfonate

Conditions
ConditionsYield
With C22H24OP(1+)*CH3O3S(1-); ammonia; copper(l) chloride at 160℃; under 73507.4 Torr; for 0.5h; Reagent/catalyst; Temperature; Pressure;95%
Stage #1: sodium 2-hydroxyethanesulfonate pH=12.5;
Stage #2: With ammonia In water at 250℃; under 135014 Torr; for 2h; Autoclave;
91%
With ammonium hydroxide; sodium hydroxide at 250℃; for 2h; Reagent/catalyst; Temperature; Autoclave;78.4%
ammonium taurate

ammonium taurate

Conditions
ConditionsYield
With sulfur dioxide at 20℃; pH=4.2; Concentration; Temperature; pH-value; Large scale;95%
thiazolidine-2-thione
134469-06-0

thiazolidine-2-thione

Conditions
ConditionsYield
With formic acid; dihydrogen peroxide In water at 0 - 5℃;93%
sulfuric acid mono-(2-amino-ethyl ester)
926-39-6

sulfuric acid mono-(2-amino-ethyl ester)

Conditions
ConditionsYield
Stage #1: sulfuric acid mono-(2-amino-ethyl ester) With ammonium sulfite monohydrate at 120℃; for 18h; Autoclave;
Stage #2: With ammonium sulfite monohydrate; sodium hydroxide In water pH=7.2; Temperature;
88.1%
With water; sodium sulfite
sulfuric acid mono-(2-amino-ethyl ester)
926-39-6

sulfuric acid mono-(2-amino-ethyl ester)

ethanolamine
141-43-5

ethanolamine

Conditions
ConditionsYield
With ammonium sulfate; sulfuric acid; ammonium sulfite monohydrate In water at 110℃; for 24h; pH=6.2 - 7.2; Autoclave;85%
2-nitro-1-ethanol
625-48-9

2-nitro-1-ethanol

sodium 2-nitroethanesulfonate
859312-16-6

sodium 2-nitroethanesulfonate

Conditions
ConditionsYield
Stage #1: 2-nitro-1-ethanol With sulfur dioxide; sodium hydroxide for 15h; pH=5.9; Autoclave;
Stage #2: sodium 2-nitroethanesulfonate With hydrogen Autoclave;
81%
ammonium isethionate

ammonium isethionate

Conditions
ConditionsYield
With ammonia pH=6.5; Autoclave;75.7%
monoethanolammonium hydrogensulfate

monoethanolammonium hydrogensulfate

Conditions
ConditionsYield
Stage #1: monoethanolammonium hydrogensulfate With 1-butyl-3-methylimidazolium chloride at 120℃;
Stage #2: With sodium sulfite at 110℃; for 8h; Temperature; Reagent/catalyst;
72%
ethene
74-85-1

ethene

Conditions
ConditionsYield
Stage #1: ethene With sulfur trioxide In acetonitrile under 38000 Torr; for 288h;
Stage #2: With hydrogenchloride In water Heating;
40%
3-sulfopropanoic acid
44826-45-1

3-sulfopropanoic acid

Conditions
ConditionsYield
With sodium azide; chloroform; sulfuric acid at 45℃;
With sodium azide; sulfuric acid for 2.5h; Heating; from 3-14C labeled educt;
cysteic acid
13100-82-8

cysteic acid

Conditions
ConditionsYield
With water at 235 - 240℃;
Decarboxylation;
L-Cysteic acid
498-40-8

L-Cysteic acid

Conditions
ConditionsYield
Decarboxylierung unter anaerober Einwirkung von Leber-Extrakt;
2,2'-dithio-bis[ethylamine]
51-85-4

2,2'-dithio-bis[ethylamine]

Conditions
ConditionsYield
With ammonium iron (II) sulfate; dihydrogen peroxide at 100℃;
With ammonium iron (II) sulfate; dihydrogen peroxide at 100℃;
2-bromoethanesulfonyl chloride
54429-56-0

2-bromoethanesulfonyl chloride

Conditions
ConditionsYield
Hydrolysis.anschl. mit wss. NH3;
2-nitro-ethanesulfonic acid
503863-49-8

2-nitro-ethanesulfonic acid

Conditions
ConditionsYield
With water; nickel Hydrogenation;
With water; nickel Hydrogenation;
Taurocholic acid
81-24-3

Taurocholic acid

N-α-Hydroxypropyl-taurin

N-α-Hydroxypropyl-taurin

A

Tau
107-35-7

Tau

B

propionaldehyde
123-38-6

propionaldehyde

Conditions
ConditionsYield
at 0 - 25℃; Equilibrium constant;
1,2-Thiazetidine 1,1-dioxide
34817-61-3

1,2-Thiazetidine 1,1-dioxide

Conditions
ConditionsYield
In water
With sodium hydroxide; potassium chloride at 30℃; Kinetics;
1-methyl-4-(phenylacetyl)pyridinium cation
124225-44-1

1-methyl-4-(phenylacetyl)pyridinium cation

2-aminoethanesulfonate
56546-93-1

2-aminoethanesulfonate

A

Tau
107-35-7

Tau

B

C14H13NO
114444-46-1

C14H13NO

Conditions
ConditionsYield
In water at 25℃; Rate constant; Equilibrium constant;
C16H36N(1+)*C6H4NO3(1-)*C2H6NO3S(1-)*H(1+)

C16H36N(1+)*C6H4NO3(1-)*C2H6NO3S(1-)*H(1+)

A

Tau
107-35-7

Tau

B

tetra-n-butylammonium p-nitrophenoxide
3002-48-0

tetra-n-butylammonium p-nitrophenoxide

Conditions
ConditionsYield
In 1,4-dioxane; water at 25℃; Equilibrium constant;
(4-hydroxy-1,2-dimethylpyrimidinium-5-yl)methanesulfonate

(4-hydroxy-1,2-dimethylpyrimidinium-5-yl)methanesulfonate

Conditions
ConditionsYield
With sodium hydroxide; sodium azide; sulfuric acid 1.) heating, 2 h .) heating, 2.5 h; Multistep reaction;
2-aminoethylthiosulfonic acid
2937-53-3

2-aminoethylthiosulfonic acid

Conditions
ConditionsYield
With sodium bromate; sodium perchlorate In water at 25℃; Product distribution; Mechanism; various reaction conditions;
With potassium iodate In water at 25℃; Mechanism;
2-[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-(E)-ylideneamino]-ethanesulfonic acid

2-[(2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraen-(E)-ylideneamino]-ethanesulfonic acid

A

Tau
107-35-7

Tau

B

all-trans-Retinal
116-31-4

all-trans-Retinal

Conditions
ConditionsYield
With phosphate buffer Rate constant; also hydrolysis in physiological solution and aq. EtOH;
hypotaurine
300-84-5

hypotaurine

Conditions
ConditionsYield
With chlorine dioxide; sodium perchlorate In water at 25℃; Rate constant; Mechanism;
hypotaurine
300-84-5

hypotaurine

A

Tau
107-35-7

Tau

B

N-chlorotaurine
51036-13-6

N-chlorotaurine

C

N-chlorohypotaurine

N-chlorohypotaurine

Conditions
ConditionsYield
With sodium perchlorate; hypochloric acid In water at 25℃; Rate constant; Mechanism;
1,3-thiazolidine
504-78-9

1,3-thiazolidine

bromine
7726-95-6

bromine

acetic acid
64-19-7

acetic acid

benzyl chloroformate
501-53-1

benzyl chloroformate

N-Benzyloxycarbonyl-taurine sodium salt
136027-16-2

N-Benzyloxycarbonyl-taurine sodium salt

Conditions
ConditionsYield
With sodium hydroxide a) 0 deg C, 30 min, b) 20 deg C, 2 h;100%
With sodium hydroxide In water for 0.5h;100%
With sodium hydroxide In 1,4-dioxane; water at 20℃; for 1h;82%
sodium taurinate
7347-25-3

sodium taurinate

Conditions
ConditionsYield
With sodium hydroxide In water at 60℃; Sonication;100%
With sodium hydrogencarbonate In water at 20℃; for 2h;100%
With sodium hydrogencarbonate In water
With sodium hydroxide In water
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tetra(n-butyl)ammonium hydroxide
2052-49-5

tetra(n-butyl)ammonium hydroxide

tetrabutylammonium 2-((tert-butoxycarbonyl)amino)ethane-1-sulfonate

tetrabutylammonium 2-((tert-butoxycarbonyl)amino)ethane-1-sulfonate

Conditions
ConditionsYield
In water; acetone at 20℃;100%
In water; acetone at 20℃;100%
99%
In water; acetone at 20℃; for 12h;95%
In water; acetone at 25℃; for 16h;
4,6,4',6'-tetrachloro-2,2'-(3,6-dioxa-octane-1,8-diyldioxy)-bis-[1,3,5]triazine
36394-85-1

4,6,4',6'-tetrachloro-2,2'-(3,6-dioxa-octane-1,8-diyldioxy)-bis-[1,3,5]triazine

C16H22Cl2N8O10S2(2-)*2Na(1+)

C16H22Cl2N8O10S2(2-)*2Na(1+)

Conditions
ConditionsYield
With sodium carbonate In tetrahydrofuran; water at 0 - 20℃;100%
calcium taurine

calcium taurine

Conditions
ConditionsYield
With calcium hydroxide In water at 20℃; for 2h; Time; Reflux;100%
acrylonitrile
107-13-1

acrylonitrile

disodium salt of N-carboxyethyltaurine

disodium salt of N-carboxyethyltaurine

Conditions
ConditionsYield
With sodium hydroxide; nitrogen In water99.8%
acrylonitrile
107-13-1

acrylonitrile

potassium salt of cyanoethyltaurine

potassium salt of cyanoethyltaurine

Conditions
ConditionsYield
With potassium hydroxide In water99.1%
glycolonitrile
107-16-4

glycolonitrile

sodium cyanoethyl taurine

sodium cyanoethyl taurine

Conditions
ConditionsYield
With sodium hydroxide In water at 20℃; for 2h;98.6%
formaldehyd
50-00-0

formaldehyd

nitromethane
75-52-5

nitromethane

N-(2-nitroethyl)taurine

N-(2-nitroethyl)taurine

Conditions
ConditionsYield
In methanol at 70℃; for 4h; Temperature; Solvent; Mannich Aminomethylation; Green chemistry;98.5%
7,8-dihydroxy-chroman-2-one
90560-41-1

7,8-dihydroxy-chroman-2-one

C11H14NO7S(1-)*Na(1+)
1228675-83-9

C11H14NO7S(1-)*Na(1+)

Conditions
ConditionsYield
With water; sodium hydroxide In 1,4-dioxane at 0 - 20℃;98%
C24H28N2O8

C24H28N2O8

N-taurine
90990-60-6

N-taurine

Conditions
ConditionsYield
With sodium hydroxide at -10 - 0℃; for 8h;97.6%
copper(I) oxide

copper(I) oxide

1,10-phenanthroline-2,9-dicarboxaldehyde
57709-62-3

1,10-phenanthroline-2,9-dicarboxaldehyde

2Na(1+)*[Cu2(C12H6N2(CHNC2H4SO3)2)2](2-)=Na2[Cu2(C12H6N2(CHNC2H4SO3)2)2]

2Na(1+)*[Cu2(C12H6N2(CHNC2H4SO3)2)2](2-)=Na2[Cu2(C12H6N2(CHNC2H4SO3)2)2]

Conditions
ConditionsYield
With NaHCO3 In water (Ar or N2); a flask charged with 1,10-phenanthroline-2,9-dicarboxaldehyde, sulfanilic acid, Cu2O, NaHCO3, sealed, purified of O2, H2O added, sealed, stirred at room temp.; evapd. (vac.);97%
C18H32N2O8

C18H32N2O8

2-((S)-2,5-Bis-tert-butoxycarbonylamino-pentanoylamino)-ethanesulfonic acid

2-((S)-2,5-Bis-tert-butoxycarbonylamino-pentanoylamino)-ethanesulfonic acid

Conditions
ConditionsYield
With sodium hydroxide at 0 - 10℃; for 2h;96.9%
di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

2–((tert-butoxycarbonyl)amino)ethyl-1-sulfonic acid

2–((tert-butoxycarbonyl)amino)ethyl-1-sulfonic acid

Conditions
ConditionsYield
With sodium hydrogencarbonate In tetrahydrofuran; methanol at 10℃; for 24h; Temperature; Cooling with ice;96%
With sodium hydroxide; water In tetrahydrofuran for 15h; Ambient temperature; Yield given;
With sodium hydroxide In tetrahydrofuran; water at 20℃;
With dmap; triethylamine In dichloromethane at 0℃;
pyridine-2-carbaldehyde
1121-60-4

pyridine-2-carbaldehyde

copper(I) oxide

copper(I) oxide

methanol
67-56-1

methanol

Na(1+)*Cu(C5H4NCHNCH2CH2SO3)2(1-)*2CH3OH = Na(Cu(C5H4NCHNCH2CH2SO3)2)*2CH3OH

Na(1+)*Cu(C5H4NCHNCH2CH2SO3)2(1-)*2CH3OH = Na(Cu(C5H4NCHNCH2CH2SO3)2)*2CH3OH

Conditions
ConditionsYield
With sodium hydrogencarbonate; tert-butyl alcohol In water-d2 (Ar or N2); pyridine-2-carboxaldehyde, taurine, Cu2O, NaHCO3 added to flask; sealed; mag. stirring-bar added; water added; flask sealed; stirredfor 8 h at 22°C; volatiles removed under dynamic vac.; methanol and tert-butanol added; pptd.; crystals allowed to settle; supernatant removed with cannula filter; dried under dynamic vac. for 4 h; elem. anal.;96%
lithium 2-aminoethanesulfonate
117998-05-7

lithium 2-aminoethanesulfonate

Conditions
ConditionsYield
Stage #1: Tau With lithium hydroxide monohydrate In water at 20℃;
Stage #2: In toluene at 100℃; for 12h;
96%
C26H28N2O10

C26H28N2O10

C23H25N3O10S

C23H25N3O10S

Conditions
ConditionsYield
With potassium hydroxide In water at -10 - 0℃; for 6h;96%
(rac)-gossypol
303-45-7

(rac)-gossypol

megosin

megosin

Conditions
ConditionsYield
With sodium hydroxide In ethanol for 3h; Heating;95.8%
cholic acid
81-25-4

cholic acid

sodium taurocholate
145-42-6

sodium taurocholate

Conditions
ConditionsYield
Stage #1: Tau; cholic acid With N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; triethylamine In N,N-dimethyl-formamide at 90℃; for 2h;
Stage #2: With sodium hydroxide In methanol at 20℃; for 1h;
95%
With N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; sodium hydroxide In water; dimethyl sulfoxide; acetonitrile; tert-butyl alcohol at 20 - 80℃;88%
Deoxycholic acid
83-44-3

Deoxycholic acid

sodium taurodeoxycholate
1180-95-6

sodium taurodeoxycholate

Conditions
ConditionsYield
With N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; sodium hydroxide In water; dimethyl sulfoxide; acetonitrile; tert-butyl alcohol at 20 - 80℃;95%
ursodeoxycholic acid
128-13-2

ursodeoxycholic acid

tauroursodeoxycholic acid sodium salt
35807-85-3

tauroursodeoxycholic acid sodium salt

Conditions
ConditionsYield
With N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; sodium hydroxide In water; acetonitrile; tert-butyl alcohol at 20 - 80℃;95%
(±)-gossypol acetic acid
5453-04-3, 866541-93-7, 1189561-66-7

(±)-gossypol acetic acid

megosin

megosin

Conditions
ConditionsYield
Stage #1: Tau With sodium hydroxide In ethanol for 1h; Reflux;
Stage #2: (±)-gossypol acetic acid In ethanol for 5h; Reflux;
94%
Stage #1: Tau With sodium hydroxide In ethanol for 1h; Reflux;
Stage #2: (±)-gossypol acetic acid In ethanol for 5h; Reflux;
94%
chenodeoxycholic acid
474-25-9

chenodeoxycholic acid

sodium taurochenodeoxycholate
6009-98-9

sodium taurochenodeoxycholate

Conditions
ConditionsYield
With N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline; sodium hydroxide In water; acetonitrile; tert-butyl alcohol at 20 - 80℃;93%

Taurine Chemical Properties

Structure Descriptors of Taurine (CAS NO.107-35-7):

IUPAC Name: 2-aminoethanesulfonic acid 
Molecular Formula: C2H7NO3S
Molecular Weight: 125.14g/mol
Mol File: 107-35-7.mol
EINECS: 203-483-8
Appearance: Large white crystals or white powder
Melting Point: >300 °C(lit.)
Storage Temperature: 2-8°C
Density: 1.494 g/cm3
Water Solubility: 5-10 g/100 mL at 23.5 ºC
Stability: Stable. Incompatible with strong oxidizing agents.
Surface Tension: 68.1 dyne/cm 
Index of Refraction: 1.515
Molar Refractivity: 25.27 cm3
Molar Volume: 83.7 cm3
XLogP3-AA: -4.1
H-Bond Donor: 2
H-Bond Acceptor: 4
Canonical SMILES: C(CS(=O)(=O)O)N
InChI: InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)  
InChIKey: XOAAWQZATWQOTB-UHFFFAOYSA-N
Product Categories: Food and Feed Additive; Food & Feed ADDITIVES; Sulphur Derivatives; pharmacetical; Natural Plant Extract; Nutritional fortification substances; Amino Acids; GABA/Glycine receptor

Taurine Uses

The uses of Taurine are as follows:
1. Taurine is an essential dietary requirement for feline health, since cats cannot synthesize the compound. The absence of taurine causes a cat's retina to slowly degenerate, causing eye problems and (eventually) irreversible blindness — a condition known as central retinal degeneration (CRD),as well as hair loss and tooth decay. It was discovered in 1987 that taurine deficiency can also cause feline dilated cardiomyopathy. Unlike CRD, the condition is reversible with supplementation. Taurine is now a requirement of the Association of American Feed Control Officials (AAFCO) and any dry or wet food product labeled approved by the AAFCO should have a minimum of 0.1% taurine in dry food and 0.2% in wet food.
2.Recent research has provided evidence that Taurine is essential in early bird development of passerines. Many passerines, regardless of spider availability, seek out many Taurine-rich spiders to feed their young particularly in their youngest stages of life. Researchers later compared the behaviors and development of birds fed a Taurine-supplemented diet to a control diet and found that juveniles that were fed Taurine-rich diets as neonates were much larger risk takers and more adept at spatial learning tasks.
3. Taurine is used as a functional food in many energy drinks and energy products. Despite being present in many energy foods, it has not been proven to be energy-giving. A study of mice hereditarily unable to transport Taurine suggests that it is needed for proper maintenance and functioning of skeletal muscles. Additionally, it has been shown to be effective in removing fatty liver deposits in humans, preventing liver disease, and reducing cirrhosis in rats.
4. Taurine is necessary for normal skeletal muscle functioning.
5.It is believed that prematurely born infants lack the enzymes needed to convert cystathionine to cysteine and may therefore become deficient in taurine. Thus, Taurine is thought to be a dietary essential nutrient in these individuals and has been added to many infant formulas as a measure of prudence, since the early 1980s.

Taurine Production

For mammalian taurine synthesis occurs in the pancreas via the cysteine sulfinic acid pathway. In this pathway, the sulfhydryl group of cysteine is first oxidized to cysteine sulfinic acid by the enzyme cysteine dioxygenase. Cysteine sulfinic acid, in turn, is decarboxylated by sulfinoalanine decarboxylase to form hypotaurine. It is unclear whether hypotaurine is then spontaneously or enzymatically oxidized to yield taurine.
Taurine in the pharmaceutical and lab setting is synthesized through a combination of cysteine, methionine, and vitamin E.
In 1993, approximately 5,000–6,000 t. of taurine were produced; 50% for pet food manufacture, 50% in pharmaceutical applications.Synthetic taurine is obtained from isethionic acid (2-hydroxyethanesulfonic acid), which in turn is obtained from the reaction of ethylene oxide with aqueous sodium bisulfite.Another approach is the reaction of aziridine with sulfurous acid. This leads directly to taurine.

Taurine Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous > 2gm/kg (2000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19, Pg. 2677, 1991.
mammal (species unspecified) LD oral > 10gm/kg (10000mg/kg)   Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 33(10), Pg. 57, 1989.
mouse LD50 intramuscular > 7gm/kg (7000mg/kg)   Drugs in Japan Vol. -, Pg. 51, 1990.
mouse LD50 intraperitoneal 6630mg/kg (6630mg/kg)   Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 18, Pg. 658, 1983.
mouse LD50 intravenous > 7gm/kg (7000mg/kg)   Drugs in Japan Vol. -, Pg. 51, 1990.
mouse LD50 oral > 7gm/kg (7000mg/kg)   Drugs in Japan Vol. -, Pg. 51, 1990.
mouse LD50 subcutaneous 6gm/kg (6000mg/kg)   Quarterly Journal of Pharmacy & Pharmacology. Vol. 19, Pg. 48, 1946.
rabbit LD50 intravenous > 1gm/kg (1000mg/kg)   Drugs in Japan Vol. -, Pg. 51, 1990.
rat LD50 intravenous > 7gm/kg (7000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19, Pg. 2671, 1991.
rat LD50 oral > 5gm/kg (5000mg/kg)   Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 19, Pg. 2671, 1991.

Taurine Safety Profile

Safety Information of Taurine (CAS NO.107-35-7):
Hazard Codes: XiIrritant
Risk Statements: 36/37/38   
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36-24/25
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing. 
S24/25:Avoid contact with skin and eyes.
WGK Germany: 2
RTECS: WX0175000
HS Code: 29211980

Taurine Specification

 Taurine , its CAS NO. is 107-35-7, the synonyms are 2-Aminoethanesulfonic acid ; 2-Aminoethylsulfonic acid ; 2-Sulfoethylamine ; Tauphon ; Taurinum ;  beta-Aminoethylsulfonic acid ; Ethanesulfonic acid, 2-amino- ; L-Taurine .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View